Brief: Pluristem Updates On Meeting With FDA On Development Plan For Acute Radiation Syndrome

Pluri

03/01/2019 13:41

Jan 3 (Reuters) - Pluristem Therapeutics Inc  PSTI.O :
    * PLURISTEM CONCLUDES POSITIVE MEETING WITH FDA ON
DEVELOPMENT
PLAN FOR ACUTE RADIATION SYNDROME
    * PLURISTEM THERAPEUTICS INC - FDA PROVIDED PLURISTEM WITH
FEEDBACK ON PROGRESS AND DATA COLLECTED ON PLX-R18 TO DATE
    * PLURISTEM THERAPEUTICS INC - FDA GAVE GUIDANCE TOWARDS
ADVANCING
DEVELOPMENT OF PLX-R18 WITH RESPECT TO TREATMENT OF ARS

Source text for Eikon:  ID:nGNX9w57s0 
Further company coverage:  PSTI.O 

 ((Reuters.Briefs@thomsonreuters.com;))